Institut Català de la Salut
[Morote J] Servei d’Urologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Departament de Cirurgia, Universitat Autònoma de Barcelona, Bellaterra, Spain. [Paesano N] Departament de Cirurgia, Universitat Autònoma de Barcelona, Bellaterra, Spain. Clínica Creu Blanca, Barcelona, Spain. [Picola N] Department of Urology, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Spain. [Muñoz-Rodriguez J] Department of Urology, Hospital Universitari Parc Taulí, Sabadell, Spain. [Ruiz-Plazas X] Department of Urology, Hospital Universitari Joan XXIII, Tarragona, Spain. [Muñoz-Rivero MV] Department of Urology, Hospital Universitari Arnau de Vilanova, Lleida, Spain. [Celma A] Servei d’Urologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain
Vall d'Hebron Barcelona Hospital Campus
2024-07-02T10:06:20Z
2024-07-02T10:06:20Z
2024-08
Prostate cancer; Early detection; Predictive models
Càncer de pròstata; Detecció precoç; Models predictius
Cáncer de próstata; Detección precoz; Modelos predictivos
Quality control of programs for detection of significant prostate cancer (sPCa) could be defined by the correlation between observed and reference 95% confidence intervals (CIs) for Prostate Imaging-Reporting and Data System (PI-RADS) categories. We used the area under the receiver operating characteristic curve (AUC) for the Barcelona magnetic resonance imaging (MRI) predictive model to screen the quality of ten participant centers in the sPCa opportunistic early detection program in Catalonia. We set an AUC of <0.8 as the criterion for suboptimal quality. Quality was confirmed in terms of the correlation between actual sPCa detection rates and reference 95% CIs. For a cohort of 2624 men with prostate-specific antigen >3.0 ng/ml and/or a suspicious digital rectal examination who underwent multiparametric MRI and two- to four-core targeted biopsies of PI-RADS ≥3 lesions and/or 12-core systematic biopsy, AUC values ranged from 0.527 to 0.914 and were <0.8 in four centers (40%). There was concordance between actual sPCa detection rates and reference 95% CIs for one or two PI-RADS categories when the AUC was <0.8, and for three or four PI-RADS categories when the AUC was ≥0.8. A review of procedures used for sPCa detection should be recommended in centers with suboptimal quality. Patient summary We tested a method for assessing quality control for centers carrying out screening for early detection of prostate cancer. We found that the method can identify centers that may need to review their procedures for detection of significant prostate cancer.
Article
Published version
English
Càncer - Detecció precoç; Pròstata - Càncer - Diagnòstic; Control de qualitat; ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Diagnosis::Early Diagnosis::Early Detection of Cancer; DISEASES::Neoplasms::Neoplasms by Site::Urogenital Neoplasms::Genital Neoplasms, Male::Prostatic Neoplasms; PUBLIC HEALTH::Environmental Health::General Aspects::Control::Quality Control; TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::diagnóstico::diagnóstico precoz::detección precoz del cáncer; ENFERMEDADES::neoplasias::neoplasias por localización::neoplasias urogenitales::neoplasias de los genitales masculinos::neoplasias de la próstata; SALUD PÚBLICA::salud ambiental::aspectos generales::control::control de calidad
Elsevier
European Urology Open Science;66
https://doi.org/10.1016/j.euros.2024.06.002
Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
Articles científics - HVH [3439]